AMLX
Amylyx Pharmaceuticals Inc

2,172
Mkt Cap
$1.57B
Volume
1.71M
52W High
$16.96
52W Low
$2.60
PE Ratio
-7.95
AMLX Fundamentals
Price
$14.30
Prev Close
$13.52
Open
$13.56
50D MA
$13.03
Beta
1.73
Avg. Volume
1.48M
EPS (Annual)
-$4.43
P/B
4.73
Rev/Employee
$710,333.33
Loading...
Loading...
News
all
press releases
First Week of AMLX March 20th Options Trading
Investors in Amylyx Pharmaceuticals Inc (Symbol: AMLX) saw new options begin trading this week, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down...
Nasdaq News: Markets·3d ago
News Placeholder
More News
News Placeholder
Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Up 6.5% - What's Next?
Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Up 6.5% - What's Next...
MarketBeat·5d ago
News Placeholder
Amylyx Pharmaceuticals (NASDAQ:AMLX) Trading Down 7.2% - Time to Sell?
Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Price Down 7.2% - Here's Why...
MarketBeat·17d ago
News Placeholder
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Consensus Rating of "Moderate Buy" by Analysts
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fourteen ratings firms that are presently covering the company, Marketbeat...
MarketBeat·20d ago
News Placeholder
Amylyx Pharmaceuticals (NASDAQ:AMLX) Director Acquires $100,845.00 in Stock
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) Director Karen Firestone purchased 8,100 shares of the company's stock in a transaction that occurred on Tuesday, December 23rd. The stock...
MarketBeat·27d ago
News Placeholder
Amylyx Pharmaceuticals (NASDAQ:AMLX) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut Amylyx Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
TFG Asset Management GP Ltd Makes New $1.40 Million Investment in Amylyx Pharmaceuticals, Inc. $AMLX
TFG Asset Management GP Ltd bought a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing...
MarketBeat·1mo ago
News Placeholder
683 Capital Management LLC Has $13.85 Million Stake in Amylyx Pharmaceuticals, Inc. $AMLX
683 Capital Management LLC lowered its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Free Report) by 10.4% during the second quarter, according to its most recent Form 13F filing...
MarketBeat·1mo ago
News Placeholder
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the fourteen analysts that are currently covering the stock...
MarketBeat·1mo ago
News Placeholder
Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx or the Company) today announced the presentation of early safety and tolerability data from its Phase 1 LUMINA trial of AMX0114 and results from...
Business Wire·2mo ago
<
1
2
...
>

Latest AMLX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.